{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:59:07Z","timestamp":1792180747000,"version":"4.4.0"},"reference-count":132,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T00:00:00Z","timestamp":1461801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide. Although most of the primary CRC can be removed by surgical resection, advanced tumors sometimes show recurrences in distant organs such as the liver, lung, lymph node, bone or peritoneum even after complete resection of the primary tumors. In these advanced and metastatic CRC, it is the tumor-stroma interaction in the tumor microenvironment that often promotes cancer invasion and\/or metastasis through chemokine signaling. The tumor microenvironment contains numerous host cells that may suppress or promote cancer aggressiveness. Several types of host-derived myeloid cells reside in the tumor microenvironment, and the recruitment of them is under the control of chemokine signaling. In this review, we focus on the functions of chemokine signaling that may affect tumor immunity by recruiting several types of bone marrow-derived cells (BMDC) to the tumor microenvironment of CRC.<\/jats:p>","DOI":"10.3390\/ijms17050643","type":"journal-article","created":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T10:25:55Z","timestamp":1461839155000},"page":"643","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":119,"title":["The Role of Chemokines in Promoting Colorectal Cancer Invasion\/Metastasis"],"prefix":"10.3390","volume":"17","author":[{"given":"Yoshiro","family":"Itatani","sequence":"first","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan"},{"name":"Moores Cancer Center, University of California, San Diego, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kawada","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Inamoto","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Taketo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan"},{"name":"Department of Pharmacology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,4,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nm1087","article-title":"Cancer genes and the pathways they control","volume":"10","author":"Vogelstein","year":"2004","journal-title":"Nat. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc2714","article-title":"Environment-mediated drug resistance: A major contributor to minimal residual disease","volume":"9","author":"Meads","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc1388","article-title":"Cancer and the chemokine network","volume":"4","author":"Balkwill","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","first-page":"50","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"140","author":"Homey","year":"2001","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"446","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.molmed.2009.06.006","article-title":"The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression","volume":"15","author":"Gao","year":"2009","journal-title":"Trends Mol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nrc2444","article-title":"The role of myeloid cells in the promotion of tumour angiogenesis","volume":"8","author":"Murdoch","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nri3789","article-title":"Immune cell promotion of metastasis","volume":"15","author":"Kitamura","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrc3581","article-title":"History of myeloid-derived suppressor cells","volume":"13","author":"Talmadge","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-\u03b2: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: A systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrc2067","article-title":"The tumor microenvironment as a target for chemoprevention","volume":"7","author":"Albini","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.20052124","article-title":"CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer","volume":"203","author":"Wang","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9754","DOI":"10.1158\/0008-5472.CAN-08-1748","article-title":"TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche","volume":"68","author":"Yamamoto","year":"2008","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ccr.2013.10.009","article-title":"CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis","volume":"24","author":"Katoh","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1038\/sj.onc.1210267","article-title":"Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes","volume":"26","author":"Kawada","year":"2007","journal-title":"Oncogene"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.27670","article-title":"The role of CXCR3 and CXCR4 in colorectal cancer metastasis","volume":"132","author":"Murakami","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ijc.21135","article-title":"Selective infiltration of CCR5+ CXCR3+ T lymphocytes in human colorectal carcinoma","volume":"116","author":"Musha","year":"2005","journal-title":"Int. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1200\/JCO.2005.07.078","article-title":"Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival","volume":"23","author":"Kim","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1158\/1078-0432.CCR-05-2142","article-title":"Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients","volume":"12","author":"Ottaiano","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1158\/1078-0432.CCR-04-1195","article-title":"Effect of chemokine receptors CXCR4 and CCR7 on the metastasis behavior of human colorectal cancer","volume":"11","author":"Schimanski","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S339","DOI":"10.1245\/s10434-011-1774-4","article-title":"CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases","volume":"19","author":"Yopp","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1245\/s10434-009-0599-x","article-title":"Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1\/CXCR4 axis","volume":"16","author":"Matsusue","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1593\/neo.09272","article-title":"CXCR4 regulates the early extravasation of metastatic tumor cells in vivo","volume":"11","author":"Gassmann","year":"2009","journal-title":"Neoplasia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1309\/AJCPK35VZJEWCUTL","article-title":"Prognostic significance of CXCL12 expression in patients with colorectal carcinoma","volume":"132","author":"Nakanishi","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10585-007-9060-3","article-title":"Chemokine expression is associated with the accumulation of tumor associated macrophages (TAMs) and progression in human colorectal cancer","volume":"2","author":"Bailey","year":"2007","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1158\/1078-0432.CCR-08-2491","article-title":"Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis","volume":"15","author":"Hu","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/hep.26094","article-title":"Recruitment of a myeloid cell subset (CD11b\/Gr1mid) via CCL2\/CCR2 promotes the development of colorectal cancer liver metastasis","volume":"57","author":"Zhao","year":"2013","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.celrep.2015.06.024","article-title":"CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function","volume":"12","author":"Chun","year":"2015","journal-title":"Cell Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2012.05.023","article-title":"Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway","volume":"22","author":"Wolf","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1158\/0008-5472.CAN-11-2493","article-title":"Tumor-derived chemokine CCL5 enhances TGF-\u03b2-mediated killing of CD8+ T cells in colon cancer by T-regulatory cells","volume":"72","author":"Chang","year":"2012","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/ng1997","article-title":"SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion","volume":"39","author":"Kitamura","year":"2007","journal-title":"Nat. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"13063","DOI":"10.1073\/pnas.1002372107","article-title":"Inactivation of Chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model","volume":"107","author":"Kitamura","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/j.gastro.2013.07.033","article-title":"Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis","volume":"145","author":"Itatani","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s10585-014-9684-z","article-title":"CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis","volume":"31","author":"Hirai","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1078-0432.CCR-15-0726","article-title":"Loss of SMAD4 promotes colorectal cancer progression by accumulation of myeloid-derived suppressor cells through CCL15\u2013CCR1 chemokine axis","volume":"22","author":"Inamoto","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Liu, J., Zhang, N., Li, Q., Zhang, W., Ke, F., Leng, Q., Wang, H., Chen, J., and Wang, H. (2011). Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019495"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood-2002-11-3577","article-title":"Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines","volume":"101","author":"Geginat","year":"2003","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e26245","DOI":"10.4161\/onci.26245","article-title":"IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patients","volume":"2","author":"Wong","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Zheng, J., Yang, M., Shao, J., Miao, Y., Han, J., and Du, J. (2013). Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis. Mol. Cancer, 12.","DOI":"10.1186\/1476-4598-12-141"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"20009","DOI":"10.1073\/pnas.1013805107","article-title":"Autocrine TGF-\u03b2 and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts","volume":"107","author":"Kojima","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Romain, B., Hachet-Haas, M., Rohr, S., Brigand, C., Galzi, J.L., Gaub, M.P., Pencreach, E., and Guenot, D. (2014). Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer. Mol. Cancer.","DOI":"10.1186\/1476-4598-13-58"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1038\/sj.onc.1209505","article-title":"Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis","volume":"25","author":"Wendt","year":"2006","journal-title":"Oncogene"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.yexcr.2005.07.006","article-title":"CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation","volume":"310","author":"Brand","year":"2005","journal-title":"Exp. Cell Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s10637-010-9578-0","article-title":"Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer","volume":"30","author":"Ma","year":"2012","journal-title":"Investig. New Drugs"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1158\/1078-0432.CCR-10-2636","article-title":"CXCL12 (SDF1\u03b1)-CXCR4\/CXCR7 pathway inhibition: An emerging sensitizer for anticancer therapies?","volume":"17","author":"Duda","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ccr.2008.01.034","article-title":"HIF1\u03b1 induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion","volume":"13","author":"Du","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1073\/pnas.1016917108","article-title":"C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells","volume":"108","author":"Hiratsuka","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1158\/1078-0432.CCR-13-0943","article-title":"Development and preclinical characterization of a humanized antibody targeting CXCL12","volume":"19","author":"Zhong","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-03-1757","article-title":"Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes","volume":"64","author":"Kawada","year":"2004","journal-title":"Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1158\/0008-5472.CAN-10-3277","article-title":"Significance and mechanism of lymph node metastasis in cancer progression","volume":"71","author":"Kawada","year":"2011","journal-title":"Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1158\/0008-5472.CAN-06-3087","article-title":"CXCL10 promotes invasion-related properties in human colorectal carcinoma cells","volume":"67","author":"Meshel","year":"2007","journal-title":"Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ijc.21269","article-title":"Clinical significance of CXCR3 and CXCR4 expression in primary melanoma","volume":"117","author":"Longo","year":"2005","journal-title":"Int. J. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1158\/1535-7163.MCT-08-0485","article-title":"CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model","volume":"8","author":"Ma","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/sj.bjc.6605078","article-title":"Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism","volume":"100","author":"Cambien","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7701","DOI":"10.1158\/0008-5472.CAN-06-0709","article-title":"Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer","volume":"66","author":"Walser","year":"2006","journal-title":"Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"43408","DOI":"10.18632\/oncotarget.6125","article-title":"CXCR3 as a molecular target in breast cancer metastasis: Inhibition of tumor cell migration and promotion of host anti-tumor immunity","volume":"6","author":"Zhu","year":"2015","journal-title":"Oncotarget"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s11033-009-9873-z","article-title":"CXCL10 expression and prognostic significance in stage II and III colorectal cancer","volume":"37","author":"Jiang","year":"2010","journal-title":"Mol. Biol. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1136\/gutjnl-2011-301179","article-title":"ColoGuideEx: A robust gene classifier specific for stage II colorectal cancer prognosis","volume":"61","author":"Agesen","year":"2012","journal-title":"Gut"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/bjc.2015.193","article-title":"Oncogenic CXCL10 signaling drives metastasis development and poor clinical outcome","volume":"113","author":"Wightman","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_68","first-page":"560","article-title":"Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer","volume":"40","author":"Toiyama","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/nm0901-1048","article-title":"Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc\u0394716 knockout mice","volume":"7","author":"Sonoshita","year":"2001","journal-title":"Nat. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2407-8-178","article-title":"ELR+ CXC chemokine expression in benign and malignant colorectal conditions","volume":"8","author":"Rubie","year":"2008","journal-title":"BMC Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cyto.2011.10.019","article-title":"Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis","volume":"57","author":"Bandapalli","year":"2012","journal-title":"Cytokine"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature03799","article-title":"Genes that mediate breast cancer metastasis to lung","volume":"436","author":"Minn","year":"2005","journal-title":"Nature"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccr.2007.12.004","article-title":"Abrogation of TGF\u03b2 signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis","volume":"13","author":"Yang","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1158\/2159-8290.CD-11-0100","article-title":"TGF-\u03b2 receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms","volume":"1","author":"Novitskiy","year":"2011","journal-title":"Cancer Discov."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1158\/0008-5472.CAN-11-1792","article-title":"Monocytic CCR2+ myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment","volume":"72","author":"Lesokhin","year":"2012","journal-title":"Cancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Zhang, B., Wang, Z., Wu, L., Zhang, M., Li, W., Ding, J., Zhu, J., Wei, H., and Zhao, K. (2013). Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057114"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"237ra67","DOI":"10.1126\/scitranslmed.3007974","article-title":"Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy","volume":"6","author":"Highfill","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1053\/gast.1997.v113.pm9322516","article-title":"Differential and regulated epression of C-X-C, C-C, and C-chemokines by human colon epithelial cells","volume":"113","author":"Yang","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nm1294","article-title":"Induction of interleukin-8 preserves the angiogenic response in HIF-1-\u03b1-deficient colon cancer cells","volume":"11","author":"Mizukami","year":"2005","journal-title":"Nat. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/ijc.25562","article-title":"Interkeukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models","volume":"128","author":"Ning","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.gastro.2012.09.057","article-title":"Mice that express human interleukin-8 have increased mobilization of immature myeloid cells, which exacerbates inflammation and accelerates colon carcinogenesis","volume":"144","author":"Asfaha","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/bjc.2012.177","article-title":"Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis","volume":"106","author":"Lee","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2010.10.004","article-title":"Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases","volume":"300","author":"Varney","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/gut.51.1.56","article-title":"Frequent loss of SMAD4\/DPC4 protein in colorectal cancers","volume":"51","author":"Salovaara","year":"2002","journal-title":"Gut"},{"key":"ref_85","first-page":"1095","article-title":"Loss of Smad4 expression predicts liver metastasis in human colorectal cancer","volume":"17","author":"Losi","year":"2007","journal-title":"Oncol. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00595-009-4028-3","article-title":"Assessment of SMAD4, p53, and Ki-67 alterations as a predictor of liver metastasis in human colorectal cancer","volume":"40","author":"Kawakami","year":"2010","journal-title":"Surg. Today"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(00)81132-0","article-title":"Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes","volume":"92","author":"Takaku","year":"1998","journal-title":"Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1593\/neo.121866","article-title":"Control of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice","volume":"15","author":"Rodero","year":"2013","journal-title":"Neoplasia"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1084\/jem.20141836","article-title":"CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages","volume":"212","author":"Kitamura","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2174\/156802610791561237","article-title":"CCR1 antagonists: What have we learned from clinical trials","volume":"10","author":"Gladue","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrrheum.2015.157","article-title":"Successes and failures of chemokine-pathway targeting in rheumatoid arthritis","volume":"12","author":"Szekanecz","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/carcin\/bgr128","article-title":"COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin\/+ mouse polyps","volume":"32","author":"Nakanishi","year":"2011","journal-title":"Carcinogenesis"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/gut.2004.059824","article-title":"Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma","volume":"55","author":"Tanaka","year":"2006","journal-title":"Gut"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jnci\/djq044","article-title":"Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth","volume":"102","author":"Zhang","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"G1087","DOI":"10.1152\/ajpgi.00252.2012","article-title":"Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: Role of MCP-1","volume":"303","author":"McClellan","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.1158\/0008-5472.CAN-09-1451","article-title":"Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice","volume":"69","author":"Popivanova","year":"2009","journal-title":"Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Marazioti, A., Kairi, C.A., Spella, M., Giannou, A.D., Magkouta, S., Giopanou, I., Papaleonidopoulos, V., Kalomenidis, I., Snyder, L.A., and Kardamakis, D. (2013). Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0071207"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1158\/1078-0432.CCR-13-0525","article-title":"Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: A role for targeting the CCL2\/CCR2 axis","volume":"19","author":"Sanford","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nature13862","article-title":"Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis","volume":"515","author":"Bonapace","year":"2014","journal-title":"Nature"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymeal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ctrv.2012.03.005","article-title":"Mesenchymal stem cell signaling in cancer progression","volume":"39","author":"Torsvik","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1172\/JCI69244","article-title":"Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis","volume":"123","author":"Chaturvedi","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa051424","article-title":"Effector memory T cells, early metastasis, and survival in colorectal cancer","volume":"353","author":"Berger","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_106","first-page":"3491","article-title":"CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer","volume":"58","author":"Naito","year":"1998","journal-title":"Cancer Res."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Cambien, B., Richard-Fiardo, P., Karimdjee, B.F., Martini, V., Ferrua, B., Pitard, B., Schmid-Antomarchi, H., and Schimid-Alliana, A. (2011). CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFR\u03b2 in colorectal carcinoma. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028842"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","article-title":"Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer","volume":"71","author":"Tosolini","year":"2011","journal-title":"Cancer Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nm.3291","article-title":"An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy","volume":"19","author":"Chung","year":"2013","journal-title":"Nat. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"8391","DOI":"10.4049\/jimmunol.181.12.8391","article-title":"CCR6 Regulates the Migration of Inflammatory and Regulatory T Cells","volume":"81","author":"Yamazaki","year":"2008","journal-title":"J. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.4049\/jimmunol.1003251","article-title":"IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer","volume":"186","author":"Kryczek","year":"2011","journal-title":"J. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/ijc.24468","article-title":"The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer","volume":"125","author":"Ghadjar","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/sji.12087","article-title":"CCR6\/CCL20 chemokine expression profile in distinct colorectal malignancies","volume":"78","author":"Frick","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/gast.1999.0029900359","article-title":"Chemokine receptor expression by human intestinal epithelial cells","volume":"117","author":"Dwinell","year":"1999","journal-title":"Gastroenterology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1200\/JCO.2005.04.1822","article-title":"Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer","volume":"24","author":"Ghadjar","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jso.23247","article-title":"Macrophage inflammatory protein-3 alpha (MIP-3\u03b1) is a novel serum prognostic marker in patients with colorectal cancer","volume":"107","author":"Iwata","year":"2013","journal-title":"J. Surg. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Nandi, B., Pai, C., Huang, Q., Prabhala, R.H., Munshi, N.C., and Gold, J.S. (2014). CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0097566"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s10620-014-3138-y","article-title":"Antitumor efficacy of CC motif chemokine ligand 19 in colorectal cancer","volume":"59","author":"Lu","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"ref_121","first-page":"153","article-title":"Decreased expression of the chemokine CCL21 in human colorectal adenocarcinomas","volume":"21","author":"Mumtaz","year":"2009","journal-title":"Oncol. Rep."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1158\/1078-0432.CCR-10-3186","article-title":"Tumor infiltration by T lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favorable outcome in patients with advanced colorectal carcinoma","volume":"18","author":"Correale","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ijc.21123","article-title":"Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7","volume":"116","author":"Leier","year":"2005","journal-title":"Int. J. Cancer"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.dld.2010.05.013","article-title":"The CCL21\/CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase-9","volume":"43","author":"Li","year":"2011","journal-title":"Dig. Liver Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1158\/1078-0432.CCR-07-1145","article-title":"Eotaxin-2 and colorectal cancer: A potential target for immune therapy","volume":"13","author":"Cheadle","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/ijc.25440","article-title":"Mesenchymal stem cells enhance growth and metastasis of colon cancer","volume":"127","author":"Shinagawa","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/cgt.2013.22","article-title":"The use of hypoxic cultured mesenchymal stem cell for oncolytic virus therapy","volume":"20","author":"Huang","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"ref_128","unstructured":"Tard\u00e1guila, M., and Ma\u00f1es, S. (2014). Oncology Theory & Practice, iConcept Press Ltd.. [1st ed.]. Chapter 8."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/gut.2005.088989","article-title":"Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer","volume":"56","author":"Vitale","year":"2007","journal-title":"Gut"},{"key":"ref_130","first-page":"41","article-title":"The high expression of Fractalkine results in a better prognosis for colorectal cancer patients","volume":"26","author":"Ohta","year":"2005","journal-title":"Int. J. Oncol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Eng. J. Med."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Network (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487, 330\u2013337.","DOI":"10.1038\/nature11252"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/5\/643\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:23:04Z","timestamp":1760210584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/5\/643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,28]]},"references-count":132,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5]]}},"alternative-id":["ijms17050643"],"URL":"https:\/\/doi.org\/10.3390\/ijms17050643","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,28]]}}}